Please login to the form below

Not currently logged in

Boehringer rebrands contract manufacturing business as BioXcellence

Hopes giving the biopharma operation its own brand will help customers

Boehringer has given its 35-year old contract manufacturing business its own brand in a move the pharma company says will help customers and the market.

The company said its new Boehringer Ingelheim BioXcellence brand would unify “the experience, dedication and commitment of this biopharmaceutical contract manufacturing business towards customers and their projects”.

Simon Sturge, senior VP of biopharmaceutcials at Boehringer Ingelheim, said: “Our new brand Boehringer Ingelheim BioXcellence will help our customers and the market identify with the quality and reliability which has made Boehringer Ingelheim's biopharmaceutical contract manufacturing business one of the largest in the world.

As a contract manufacturing and development company Boehringer Ingelheim BioXcellence will offer an entire product technology chain from DNA to fill and finish within its facilities in Biberach (Germany), Vienna (Austria) and Fremont (US).

19th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...